Maximizing Energy and Reducing Fatigue in Breast Cancer Survivors
Launched by UNIVERSITY OF PITTSBURGH · Mar 10, 2025
Trial Information
Current as of April 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Maximizing Energy and Reducing Fatigue in Breast Cancer Survivors," is looking at a program designed to help women who have finished their breast cancer treatment manage their fatigue. The researchers want to find out if women will join and stick with the program, and if it really helps them feel less tired compared to a general health education program.
To participate, women need to be 18 years or older, have been diagnosed with early-stage breast cancer, and have completed their main treatment at least six months ago. They should also be experiencing moderate to severe fatigue. Participants will take part in six online sessions over the internet, where they will learn techniques to boost their energy. Before and after these sessions, they will complete some tests to see if their fatigue improves. If you're interested and meet the criteria, this study could be a valuable opportunity to address fatigue after breast cancer treatment.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • adult (18 years and older) pre and post-menopausal female at birth diagnosed with Stages I-IIIa breast cancer,
- • completed primary treatment for breast cancer (surgery, chemotherapy, radiation) at least 6 months prior to ensure that fatigue is stable and chronic, - moderate to severe fatigue based on score ≥ 4 on the 7-point Fatigue Severity Scale,
- • able to speak and understand English
- • has a mobile device that runs on the Apple or Android platform
- Exclusion Criteria:
- • major depressive disorder, mania, hypomania, psychosis, or substance abuse in the past 3 months and
- • disability due to diagnoses other than breast cancer.
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Patients applied
Trial Officials
Ketki Raina, PhD, OTR/L, FAOTA
Principal Investigator
University of Pittsburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported